NCT00273312 - Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

October 31, 2006

Conditions

Hepatocellular Carcinoma

Interventions

DRUG

Patupilone

Patupilone was in dosage strength of 10 mg/4 mL as a clear, colorless concentrate for solution for injection in individual 10 mL glass vials

Trial Locations (7)

Novartis Investigative Site, Taipei

Novartis Investigative Site, San Francisco

Novartis Investigative Site, Hong Kong

Novartis Investigative Site, Tai Chung Municipality

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul